| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $7.5B | $7.4B | $6.1B | 1.7% | 22.0% |
| Op. Income | $833M | $645M | $355M | 29.2% | 134.4% |
| Gross Margin | 36.5% | 35.0% | 34.1% | 1.5pp | 2.4pp |
| Net Margin | 8.2% | 5.9% | 3.6% | 2.4pp | 4.6pp |
| EPS (Diluted) | $0.20 | $0.14 | $0.07 | 44.3% | 187.8% |
| Free Cash Flow | $0 | $0 | -$935M | — | 100.0% |
| Item | Amount |
|---|---|
| REVENUE | $7.5B |
| Cost of Revenue | $4.8B |
| GROSS PROFIT | $2.7B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $1.2B |
| SG&A Expenses | $1.2B |
| Other Expenses | $739M |
| Operating Expenses | $1.9B |
| Cost & Expenses | $6.6B |
| OPERATING INCOME | $833M |
| Interest Income | $4.8B |
| Interest Expense | $4.8B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $833M |
| Income Tax Expense | $221M |
| Net Income from Continuing Ops | $612M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $616M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $616M |
| D&A | $0 |
| EBIT | $833M |
| EBITDA | $833M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $7.5B |
| Cost of Revenue | $4.8B |
| GROSS PROFIT | $2.7B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $1.2B |
| SG&A Expenses | $1.2B |
| Other Expenses | $739M |
| Operating Expenses | $1.9B |
| Cost & Expenses | $6.6B |
| OPERATING INCOME | $833M |
| Interest Income | $4.8B |
| Interest Expense | $4.8B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $833M |
| Income Tax Expense | $221M |
| Net Income from Continuing Ops | $612M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $616M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $616M |
| D&A | $0 |
| EBIT | $833M |
| EBITDA | $833M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $616M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$616M |
| Change in Working Capital | $0 |
| OPERATING CASH FLOW | $0 |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $0 |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $0 |
| FREE CASH FLOW | $0 |
| Net Change in Cash | $0 |
| Item | Amount |
|---|---|
| Cash & Equivalents | $36.3B |
| Short-Term Investments | $0 |
| Net Receivables | $9.3B |
| Inventory | $0 |
| Other Current Assets | $1.6B |
| TOTAL CURRENT ASSETS | $47.2B |
| PP&E (Net) | $2.8B |
| Goodwill | $0 |
| Intangible Assets | $193M |
| Long-Term Investments | $42.0B |
| Tax Assets | $155M |
| Other Non-Current Assets | $267.6B |
| TOTAL NON-CURRENT ASSETS | $312.8B |
| TOTAL ASSETS | $360.0B |
| Account Payables | $8.1B |
| Short-Term Debt | $117.9B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $89.2B |
| TOTAL CURRENT LIABILITIES | $218.1B |
| Long-Term Debt | $84.3B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $636M |
| Other Non-Current Liabilities | $34.6B |
| TOTAL NON-CURRENT LIABILITIES | $120.6B |
| TOTAL LIABILITIES | $338.7B |
| Common Stock | $3.7B |
| Additional Paid-In Capital | $4.3B |
| Retained Earnings | $11.2B |
| Treasury Stock | -$905M |
| Accum. Other Comp. Income | $2.3B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $20.7B |
| Minority Interest | $599M |
| TOTAL EQUITY | $21.3B |
| TOTAL LIABILITIES & EQUITY | $360.0B |
| Total Debt | $203.3B |
| Net Debt | $167.0B |
